Please ensure Javascript is enabled for purposes of website accessibility
top of page

MAKING GENETIC THERAPIES AFFORDABLE AND ACCESSIBLE

The IGI brings together scientists and innovators from diverse disciplines to unlock the potential

of CRISPR technology to solve some of humanity’s greatest challenges. IGI researchers innovate

in biomedicine, agriculture, climate science, and genome engineering. The institute is working

toward a world in which genomic technologies are deployed in an ethical, socially responsible, and

equitable manner.


Click below for download:


Affordability-Task-Force-final
.pdf
Download PDF • 1.51MB

Disclaimer: This document is the work product of the N=1 Collaborative (the “N1C”), and is offered as an example only. The N1C is not providing legal or regulatory advice for N=1 trials. This document should not be construed as legal or regulatory advice for any particular purpose. Any future use of this document should be tailored to specific trials based, for example, on pre-clinical data ASO chemistry and mechanism, patient disease, and evolving body of knowledge, and where appropriate, should separately be subjected to legal review.

33 views

Comments


bottom of page